Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
J Med Primatol ; 41(3): 176-82, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22380733

ABSTRACT

BACKGROUND: Rhesus monkeys were used as a non-human primate model to study small non-coding RNA after infection with human sporadic and variant Creutzfeldt-Jakob prions. METHODS: Tissue-specific Alu DNA element transcription and editing of transcripts were assessed in neuronal - and blood cells (Buffy Coat). RESULTS: Tissue/cell-specific transcription and editing patterns were obtained. Active Alu DNA elements belonged to several Alu DNA families, they could be located on several chromosomes, and their genomic sites were identified. Deamination by adenosine deaminase acting on RNA and apolipoprotein B editing complex was found. CONCLUSIONS: Different Alu transcription and editing programmes exist and may depend on the infection status.


Subject(s)
Alu Elements/genetics , DNA/genetics , Macaca mulatta , Monkey Diseases/genetics , Neurons/metabolism , Prion Diseases/veterinary , Animals , Base Sequence , Cerebellum/cytology , Cloning, Molecular , Monkey Diseases/pathology , Prion Diseases/genetics , Prion Diseases/pathology , RNA Processing, Post-Transcriptional , Sequence Alignment
2.
J Microsc ; 230(Pt 2): 224-32, 2008 May.
Article in English | MEDLINE | ID: mdl-18445151

ABSTRACT

The conformational transition of alpha-helix-rich cellular prion protein (PrP(C)) to an isomer with high beta-sheet content is associated with transmissible spongiform encephalopathies. With the ultimate long-term goal of using imaging techniques to study PrP aggregation, we report the results of initial experiments to determine whether PrP molecules could be visualized as single molecules, and if the observed size corresponded to the calculated size for PrP. The investigation of single molecules, and not those embedded into larger aggregates, was the key in our experimental approach. Using atomic force microscopy (AFM) as an imaging method, the immobilization of recombinant histidine (His)10-tagged PrP on mica was performed in the presence of different heavy metal ions. The addition of Cu2+ resulted in an enhanced PrP immobilization, whereas Ni2+ reduced coverage of the surface by PrP. High-resolution data from dried PrP preparations provided a first approximation to geometrical parameters of PrP precipitates, which indicated that the volume of a single PrP molecule was 30 nm3. Molecular dynamics simulations performed to complement the structural aspects of the AFM investigation yielded a calculated molecular volume of 33 nm3 for PrP. These experimentally observed and theoretically expected values provide basic knowledge for further studies on the size and composition of larger amyloidal PrP aggregates, PrP isoforms or mutants such as PrP molecules without octarepeats.


Subject(s)
Microscopy, Atomic Force/methods , Prions/chemistry , Prions/ultrastructure , Aluminum Silicates/chemistry , Amyloid/chemistry , Amyloid/ultrastructure , Animals , Cattle , Metals, Heavy , Models, Molecular , Prions/genetics , Protein Folding , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/ultrastructure
3.
J Med Primatol ; 36(3): 124-30, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17517086

ABSTRACT

BACKGROUND: A 14-year-old female rhesus monkey (Macaca mulatta) of Chinese origin has been suffering from alopecia universalis since childhood. METHODS: Recently, the health status of the animal was recorded comprehensively by detailed clinical examination including hematology and serology supplemented by histological and immunohistochemical investigations of skin biopsies and molecular biological techniques to clarify the causes of the persistent hair loss. RESULTS AND CONCLUSIONS: The hairless gene (hr) nonsense mutation was ruled out by polymerase chain reaction and by sequencing of the corresponding gene. Histological examinations revealed a prominent chronic lymphocytic perifolliculitis and folliculitis affecting anagen stage hair follicles as well as miniaturized hair follicles. Immunohistochemistry using the antibodies CD3, CD20 and CD4 confirmed the diagnosis of a T-cell-mediated autoimmune disease resembling alopecia areata universalis in humans.


Subject(s)
Alopecia Areata/veterinary , Autoimmune Diseases/veterinary , Macaca mulatta , Monkey Diseases/immunology , Alopecia Areata/genetics , Alopecia Areata/immunology , Animals , Antibodies/analysis , Antibodies/metabolism , Antigens, CD/immunology , Autoimmune Diseases/diagnosis , DNA Primers/chemistry , Female , Hair Follicle/pathology , Monkey Diseases/diagnosis , Monkey Diseases/genetics , Nails/pathology , Polymerase Chain Reaction/veterinary , Skin/immunology , Skin/pathology , Thyroid Hormones/blood
4.
Int J Med Sci ; 2(4): 122-8, 2005.
Article in English | MEDLINE | ID: mdl-16239949

ABSTRACT

Diffuse large B-cell lymphoma (DLBCL) is more prevalent and more often fatal in HIV-infected patients and SIV-infected monkeys compared to immune-competent individuals. Molecular, biological, and immunological data indicate that virus-associated lymphomagenesis is similar in both infected hosts. To find genes specifically overexpressed in HIV/SIV-associated and non-HIV/SIV-associated DLBCL we compared gene expression profiles of HIV/SIV-related and non-HIV-related lymphomas using subtractive hybridization and Northern blot analysis. Our experimental approach allowed us to detect two genes (a-myb and pub) upregulated solely in HIV/SIV-associated DLBCLs potentially involved in virus-specific lymphomagenesis in human and monkey. Downregulation of the pub gene was observed in all non-HIV-associated lymphomas investigated. In addition, we have found genes upregulated in both non-HIV- and HIV-associated lymphomas. Among those were genes both with known (set, ND4, SMG-1) and unknown functions. In summary, we have demonstrated that simultaneous transcriptional upregulation of at least two genes (a-myb and pub) was specific for AIDS-associated lymphomas.

5.
Gesundheitswesen ; 66 Suppl 1: S21-5, 2004 Feb.
Article in German | MEDLINE | ID: mdl-14770333

ABSTRACT

Prion diseases of animals and man are neurological diseases with amyloidal deposition of the respective proteins. As to prion disease, the cellular prion protein is in its abnormal isoform(s) an essential component of prion protein aggregates found in affected tissue. In contrast to all neurodegenerative diseases like Morbus Alzheimer or Huntington's disease, prion diseases are transmissible. Therefore, prion diseases were designated Transmissible Spongiform Encephalopathies (TSE). The diseases have been well known for decades. Scrapie was first described around 1750, a BSE case was reported in the 1850-ties most likely a misdiagnosis, and in 1920/1930 the human Creutzfeldt-Jakob disease (CJD) had been described. Transmission of CJD i. e. Kuru had been suspected in the early 1950 s and was erroneously classified as slow virus disease. The CJD transmission posed a problem to humans when transplants from CJD cases were used for treatment. Fortunately, these iatrogenic transmissions remained limited. But with the advent of BSE and appearance of variant CJD cases in the UK and some places in Europe scientists suspected that transmission from cattle to man could have happened. From animal models we know of successful transmission via several routes. Species barriers do not completely prevent transmission. Rather, transmission barriers might exist controlling individual susceptibility against prions. Modes of transmission, susceptibility to transmission, identification of receptor molecules as well as molecular mechanisms of the transmission process are being investigated with great intensity. Current knowledge leads us to assume that inapparent stages of prion infection wrongly suggest a (non-existent) species barrier. This inapparent infection precedes overt disease, and, hence, most research focuses on the development of highly sensitive assay systems for detection of minute amounts of pathological prion protein in suspected cases. Inapparence also should warn us to underestimate BSE or human vCJD cases; at present, approx. 145 cases occurred in Europe and one probable case in Hong Kong (June 2003). Whether BSE had spread to other parts of the world by animal nutrition components or meat can neither be excluded nor confirmed at this time. New data on transmission and consequences of BSE for the human population are summarised in this review.


Subject(s)
Encephalopathy, Bovine Spongiform/epidemiology , Prion Diseases/epidemiology , Animals , Cattle , Creutzfeldt-Jakob Syndrome/epidemiology , Creutzfeldt-Jakob Syndrome/transmission , Disease Susceptibility , Encephalopathy, Bovine Spongiform/diagnosis , Encephalopathy, Bovine Spongiform/genetics , Enzyme-Linked Immunosorbent Assay , Humans , Mice , Polymerase Chain Reaction , Polymorphism, Genetic , Prion Diseases/diagnosis , Prion Diseases/genetics , Prion Diseases/transmission , Prions/analysis , Rabbits , Scrapie/epidemiology , Scrapie/transmission , Sheep , Time Factors
6.
Dtsch Tierarztl Wochenschr ; 109(8): 338-41, 2002 Aug.
Article in German | MEDLINE | ID: mdl-12224460

ABSTRACT

Prion diseases of animal and man belong to neurological diseases with amyloidal deposition of the respective proteins. As to prion disease, the cellular prionprotein is in its abnormal isoform(s) an essential component of prionprotein aggregates found in affected tissue. In contrast to all neurodegenerative diseases like Morbus Alzheimer or Huntington's disease, prion diseases are transmissible. Therefore, prion diseases were designated Transmissible Spongiform Encephalopathies (TSE). The diseases are well known since decades. Scrapie was first described around 1750, a BSE case was reported in the 1850, most likely a misdiagnosis, and in 1920/1930 the human Creutzfeldt-Jakob disease (CJD) had been described. Transmission of CJD i.e. Kuru had been suspected in the early 1950s and erronously classified as slow virus disease. The CJD transmission posed a problem to humans when transplants from CJD cases were used for treatment. Fortunately, these iatrogenic transmissions remained limited. But with the advent of BSE and appearance of variant CJD cases in the UK and some places in Europe scientists suspected that transmission from cattle to man could have happened. From animal models we know of successful transmission via several routes. Species barriers do not completely prevent transmission. Rather transmission barriers might exist controlling individual susceptibility against prions. Modes of transmission, susceptibility for transmission, identification of receptor molecules as well as molecular mechanisms of the transmission process are intensely investigated. Current knowledge let us to assume that inapparent stages of prion infection pretend a (not existing) species barrier. This inapparent infection preceeds overt disease and, thus, most re-search focuses on the development of highly sensitive assay systems for detection of minute amounts of pathological prionprotein in suspected cases. Inapparence also should warn us to underestimate BSE or human vCJD cases; at present, 124 in Europe and one probable case in Hongkong (7 March 2002). Whether BSE had spread to other parts of the world by animal nutrition components or meat can neither be excluded nor confirmed at this time. New data on transmission and consequences of BSE for the human population are summarized in this review.


Subject(s)
Encephalopathy, Bovine Spongiform/transmission , Food Contamination , Prion Diseases/transmission , Animals , Cattle , Creutzfeldt-Jakob Syndrome/etiology , Creutzfeldt-Jakob Syndrome/transmission , Disease Susceptibility , Encephalopathy, Bovine Spongiform/diagnosis , Humans , Huntington Disease/etiology , Prion Diseases/diagnosis , Prion Diseases/etiology , Scrapie/transmission , Species Specificity , Zoonoses
7.
Acta Virol ; 46(3): 159-67, 2002.
Article in English | MEDLINE | ID: mdl-12580378

ABSTRACT

The level of expression of the host PrP gene (PRNP) has been shown to affect the progression to a disease, transmissible spongiform encephalopathy (TSE). In order to define sequences that are responsible for translation ofPRNPmRNA we have investigated a region comprising its 5'-leader sequence. Most remarkable, it consists of an almost identical Kozak mRNA sequence and two AUG initiation codons which seem to modulate translation of the prion protein mRNA in vitro. Although transcriptional regulation of the prion protein PRNP gene had been expected to dominate the translational modulation, our observations point to a translational regulation of the mouse prion protein synthesis controlled by ribosomal entry and usage of AUG codons.


Subject(s)
Amyloid/genetics , Codon, Initiator , Prions/genetics , Protein Biosynthesis , Protein Precursors/genetics , 5' Untranslated Regions , Amyloid/biosynthesis , Animals , Base Sequence , Cells, Cultured , Gene Expression , Genes, Reporter/genetics , Mice , Models, Genetic , Prion Diseases/genetics , Prion Proteins , Prions/biosynthesis , Protein Precursors/biosynthesis , RNA, Messenger/physiology
8.
J Med Virol ; 65(1): 114-20, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11505452

ABSTRACT

During the course of simian immunodeficiency virus (SIV) infection, nearly 15% of rhesus macaques (Macaca mulatta) and up to 40% of cynomolgus macaques (Macaca fascicularis) developed SIV-associated non-Hodgkin's lymphomas. Most of these malignant lymphomas harbored lymphocryptoviruses, which are closely related to the human Epstein-Barr virus (EBV; Herpesvirus M. mulatta and Herpesvirus M. fascicularis). To characterize the oncogenic role of simian EBV infection for lymphomagenesis during SIV infection, expression of the EBV-encoded latent membrane protein-1 (LMP-1) was analyzed in malignant lymphomas of SIV-infected rhesus macaques. Nine seropositive rhesus macaques suffering from B-cell lymphomas during the late phase of SIV infection were euthanized. Latency stages of EBV infection within malignant lymphomas and simian EBV-infected lymphoblastoid cell lines (LCL8664, H50) were characterized by analyzing expression of the EBV-encoded nuclear antigens EBNA-1, EBNA-2, and small RNAs EBER1/2. In parallel, the presence of viral LMP-1 transcripts was assessed by reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization. Results were compared with findings in AIDS-associated malignant lymphomas in two patients infected with human immunodeficiency virus (HIV)-1. Rhesus macaques developed high-grade B-cell lymphomas of the centroblastic (five of nine), immunoblastic (two of nine), centroblastic-centrocytic (one of nine), and Burkitt-like (one of nine) subtypes within 18-29 months postinfection with SIV(mac)251/32H. The presence of Herpesvirus M. mulatta was detected in eight of nine cases. Transcription of the viral oncogene LMP-1 could be demonstrated within the simian EBV-infected cell lines as well as in four of nine SIV-associated malignant lymphomas. These four cases and both of the HIV-1-related non-Hodgkin's lymphomas expressed the full spectrum of latent EBV gene products (LMP-1, EBER1/2, EBNA-1, EBNA-2) and were thus classified as latency type III stages of EBV infection. Simian EBV infection was demonstrated in 90% of lymphomas in SIV-infected rhesus macaques. Analysis of LMP-1 expression suggests an important role for this viral oncogene in the pathogenesis of both SIV and HIV-1-associated malignant lymphomas.


Subject(s)
Disease Models, Animal , Epstein-Barr Virus Infections/virology , HIV Infections/complications , Herpesvirus 4, Human/metabolism , Lymphoma, AIDS-Related/virology , Simian Acquired Immunodeficiency Syndrome/complications , Viral Matrix Proteins/metabolism , Animals , B-Lymphocytes/virology , Cell Line, Transformed , DNA, Complementary , Humans , In Situ Hybridization , Macaca fascicularis , Macaca mulatta , Reverse Transcriptase Polymerase Chain Reaction , Simian Immunodeficiency Virus , Tumor Cells, Cultured , Viral Matrix Proteins/genetics
9.
Neoplasia ; 3(2): 132-42, 2001.
Article in English | MEDLINE | ID: mdl-11420749

ABSTRACT

Several novel, differentially transcribed genes were identified in one centroblastic and one immunoblastic HIV-associated B-cell non-Hodgkin's lymphoma (B-NHL) by subtractive cloning. In both lymphomas, we detected an upregulated transcription of several mitochondrial genes. In the centroblastic B-NHL, we found a high level transcription of nuclear genes including the interferon-inducible gene (INF-ind), the immunoglobulin light chain gene (IgL), the set oncogene, and several unknown genes. The data obtained on upregulated expression of the genes in human B-NHL of HIV-infected patients considerably overlap with those obtained earlier for the B-NHL of simian immunodeficiency virus-infected monkeys. In the centroblastic lymphoma, one transcript revealed a fusion of the 3'-untranslated region of the set gene and the C-terminal region of the IgL gene. This chimeric sequence was confirmed by a site-directed polymerase chain reaction performed with total cDNA and genomic DNA. The expected amplification product was obtained in both cases pointing to a genomic rearrangement. The IgL-set fusion sequence was not found in cDNA preparations and genomic DNA of the immunoblastic HIV-associated B-NHL. Further studies are necessary to determine whether these genes contribute to lymphoma development or can be used as therapeutic targets.


Subject(s)
Lymphoma, AIDS-Related/metabolism , Lymphoma, Non-Hodgkin/virology , RNA, Messenger/metabolism , Transcription, Genetic , 3' Untranslated Regions , Base Sequence , Blotting, Northern , Blotting, Southern , Cloning, Molecular , DNA, Complementary/metabolism , Databases, Factual , Dose-Response Relationship, Drug , Humans , Immunoblotting , Immunoglobulins/metabolism , Lymphoma/metabolism , Molecular Sequence Data , Polymerase Chain Reaction , Sequence Homology, Nucleic Acid , Up-Regulation
10.
S Afr Med J ; 90(5): 518-20, 2000 May.
Article in English | MEDLINE | ID: mdl-10901827

ABSTRACT

OBJECTIVES: Puerperal psychosis was studied in black African women at Baragwanath Hospital in Johannesburg. DESIGN: A retrospective study analysed the clinical notes of 314 cases of puerperal psychosis seen over previous years. A prospective study researched 67 cases of puerperal psychosis referred during a full calendar year. A control group of 98 patients was matched with the prospective study patients for age, marital status, parity and month of delivery. RESULTS: The incidence (2-3 cases per 1,000 births), onset and pattern of illness are all remarkably similar to that described in the international literature. Confirmed risk factors were a primiparous patient; a family history of psychiatric illness; and a personal psychiatric history, particularly a history of mania. Additional risk factors found in this study were substance dependence; a medical illness; the season of the year; a male child; and psychosocial stress including need for intensive medical care for the baby or death of the baby. CONCLUSION: The conclusion reached is that the puerperal psychoses are undifferentiated psychoses, usually mood disorders, showing some special symptomatology, and are precipitated in constitutionally predisposed patients by the physiological factors of the involutionary period.


Subject(s)
Psychotic Disorders/epidemiology , Puerperal Disorders/epidemiology , Adult , Bipolar Disorder/epidemiology , Black People , Female , Humans , Pregnancy , Prospective Studies , Retrospective Studies , Risk Factors , Seasons , South Africa/epidemiology , Urban Population
11.
Dermatology ; 200(4): 320-3, 2000.
Article in English | MEDLINE | ID: mdl-10894964

ABSTRACT

A 50-year-old man presented with recurrent tumorous lesions on the penis and the anal region. The anal lesion was histologically diagnosed as verrucous carcinoma (VC) and the penile lesions were in line with condylomata acuminata. Samples taken from tumors of both sites were human papillomavirus (HPV) DNA positive. Two of them taken from the penis and the perianal region scored HPV DNA 6 positive by using polymerase chain reaction and the Southern blot method. Treatment of both VC and condylomata acuminata consisted in surgery and adjuvant immune therapy. Neither tumor recurrence nor metastases occurred up until 6 months after therapy.


Subject(s)
Anus Neoplasms/pathology , Carcinoma, Verrucous/pathology , Condylomata Acuminata/pathology , Penile Diseases/pathology , Anus Neoplasms/virology , Carcinoma, Verrucous/virology , Condylomata Acuminata/virology , DNA, Viral/genetics , Female , Humans , Male , Middle Aged , Papillomaviridae/genetics , Papillomavirus Infections/virology , Penile Diseases/virology , Tumor Virus Infections/virology
12.
Blood ; 95(10): 3256-61, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10807797

ABSTRACT

Human T cells are transformed in vitro to stable growth after infection with herpesvirus saimiri subgroup C strain C488, and they retain their antigen-specific reactivity and other important functional features of mature activated T lymphocytes. The virus persists as nonintegrating episomes in human T cells under restricted viral gene expression and without production of virus particles. This study analyzes the behavior of herpesvirus-transformed autologous T cells after reinfusion into the donor under close-to-human experimental conditions. T cells of 5 macaque monkeys were transformed to stable interleukin-2 dependent growth and were intravenously infused into the respective donor. The animals remained healthy, without occurrence of lymphoma or leukemia for an observation period of more than 1 year. Over several months virus genomes were detectable in peripheral blood cells and in cultured T cells by polymerase chain reaction. In naive control animals, a high-dose intravenous infection rapidly induced pleomorphic peripheral T-cell lymphoma. In contrast, monkeys were protected from lymphoma after challenge infection if they had previously received autologous T-cell transfusions. High levels of antibodies against virus antigens were detectable after challenge infection only. Taken together, herpesvirus-transformed T cells are well tolerated after autologous reinfusion. This may allow us to develop a novel concept for adoptive T-cell mediated immunotherapy.


Subject(s)
Cell Transformation, Viral , Herpesvirus 2, Saimiriine , Immune Tolerance , Lymphoma/etiology , Lymphoma/pathology , T-Lymphocytes/pathology , Adoptive Transfer , Animals , Blood Transfusion, Autologous , Humans , Immunotherapy, Adoptive , Lymphocyte Transfusion , Macaca mulatta , T-Lymphocytes/immunology , T-Lymphocytes/virology
13.
AIDS Res Hum Retroviruses ; 16(2): 173-9, 2000 Jan 20.
Article in English | MEDLINE | ID: mdl-10659056

ABSTRACT

Infection with SIVmac251 in some rhesus monkeys (Macaca mulatta) leads to B-cell non-Hodgkin's lymphomas (B-NHL) clinically similar to that of HIV-infected AIDS patients. To further characterize the SIV-associated B-NHL we have generated genetic profiles of malignant cells by subtractive hybridization and Northern blot analysis. We have analyzed 21 clones of a subtracted cDNA library corresponding to overexpressed genes in diffuse large B-cell (DLBCL) SIV-associated monkey lymphoma. Eight of these clones represent a sequence homologous to an abundant transcript from KG-1 cells originally established from a human myelogenous leukemia. The protein encoded has a 60% similarity to a hypothetical glycine-rich transmembrane signal protein of Caenorhabditis elegans and 25% similarity to the ret finger protein. The other cDNA clones contained sequences of the serum amyloid A gene (SAA), the alpha1-acid glycoprotein gene (AGP), the ribosomal protein S3a (RPS3a) and L8 (RPL8) genes, the interferon-inducible gene (INF-ind), the metastasin gene (mts1), and the NADH dehydrogenase I gene (ND-I). The remaining cDNA clones consisted of yet unknown sequences. In addition, we detected an up-regulation of the cytochrome c oxidase II gene (COX-II), the ND-IV gene, and the SET oncogene by Northern blot hybridization in three SIV-associated NHLs of different histomorphological classification. All these genes have not previously been found to be overexpressed in B-NHL.


Subject(s)
Lymphoma, B-Cell/metabolism , RNA, Neoplasm/analysis , Simian Acquired Immunodeficiency Syndrome/complications , Animals , Blotting, Northern , Gene Expression , Humans , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/virology , Macaca mulatta , Simian Immunodeficiency Virus
14.
Arch Virol Suppl ; (16): 217-26, 2000.
Article in English | MEDLINE | ID: mdl-11214925

ABSTRACT

Following the BSE epidemic in cattle and the emergence of a variant form of Creutzfeldt-Jakob disease in humans, the question was raised whether BSE has been transmitted to small ruminants by the inadvertent feeding of infectious meat and bone meal. Such infections could easily be concealed in countries where scrapie is endemic. To address this issue by immuno-chemically analyzing the PrP(Sc) fragments, we have developed two lines of research. Firstly we have focused on the development of criteria for the differential characterization of experimental BSE and scrapie strains/isolates in rodents. To date, three criteria have been identified: quantification of the relative banding intensities of PrP(Sc) glycotypes using a photoimaging technique; the non-uniform kinetic of proteinase K degradation of PrP(Sc); and differences in the molecular masses of their non-glycosylated PrP(Sc) fragments after PK cleavage in immunoblot. The second line of research focused on the implementation of the criteria described above to representative samples from scrapie diseased Irish sheep. Using these three criteria, no evidence was found for the presence of a BSE infection in these animals. However, the final conclusion must take into account the results of mouse incubation time and mouse lesion profile data which are currently being generated.


Subject(s)
Encephalopathy, Bovine Spongiform/etiology , PrPSc Proteins/classification , Scrapie/etiology , Amino Acid Sequence , Animals , Cattle , Encephalopathy, Bovine Spongiform/transmission , Mice , Mice, Inbred C57BL , Molecular Sequence Data , PrPSc Proteins/chemistry , PrPSc Proteins/genetics , Sheep
15.
AIDS Res Hum Retroviruses ; 15(16): 1477-85, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10555111

ABSTRACT

Cytokine dysregulation is accepted as one of the pivotal factors in the pathogenesis of B cell lymphomas in HIV-positive patients. So far no data exist on inhibitory cytokines in the regulatory network of HIV-associated B-NHL. Simian immunodeficiency virus (SIV)-infected macaques are a well-established in vivo model of HIV infection in humans. We used this model for the identification of TGF-beta as a growth-inhibitory cytokine of SIV-associated B cell lymphomas. Fifty-seven rhesus macaques were infected with SIVmac. Nine animals developed B cell lymphomas: eight with high-grade lymphomas of the immunoblastic, centroblastic, and "Burkitt-like" type, and one with the centroblastic/centrocytic type according to the Kiel classification. Six of seven analyzed lymphomas were infected with the macaque EBV, herpes virus macaca mulatta (HVMM). The lymphomas and the SIV-associated B cell lymphoma cell line H50 were positive for transcription of the TGF-beta gene. Protein expression and secretion of the active cytokine were proved by immunohistochemistry and ELISA. H50 transcribed the TGF-beta type I and type II receptor (R I/II), betaglycan, and endoglin. Furthermore, all primary lymphoma samples tested were positive for receptor type I/II transcription and protein expression. TGF-beta induced reduction of cell viability by 67% (range, 50-84% and enhanced apoptosis by 69% (range, 33-111%) compared with the control. TGF-beta activity was blocked by a specific anti-TGF-beta antibody. Thus, TGF-beta fulfilled the criteria of a negative autocrine inhibitor in H50. These data identify TGF-beta as a promising candidate as an inhibitory factor in the regulatory network of HIV-associated lymphomagenesis.


Subject(s)
Growth Inhibitors/pharmacology , Lymphoma, AIDS-Related/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus , Transforming Growth Factor beta/pharmacology , Animals , Base Sequence , DNA, Complementary/genetics , Enzyme-Linked Immunosorbent Assay , Growth Inhibitors/metabolism , Immunohistochemistry , Lymphoma, AIDS-Related/metabolism , Lymphoma, AIDS-Related/pathology , Macaca mulatta , Molecular Sequence Data , Receptors, Transforming Growth Factor beta/genetics , Receptors, Transforming Growth Factor beta/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Simian Acquired Immunodeficiency Syndrome/metabolism , Transforming Growth Factor beta/metabolism , Tumor Cells, Cultured
16.
J Biotechnol ; 73(2-3): 119-29, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10486922

ABSTRACT

Prion diseases belong to a group of neurodegenerative disorders affecting humans and animals. The human diseases include kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI). The pathomechanisms of the prion diseases are not yet understood. Therefore, monoclonal antibodies (mAbs) would provide valuable tools in diagnostics as well as in basic research of these diseases. In contrast to conventional strategies we have developed an immunization protocol based on nucleic acid injection into non tolerant PrP0/0-mice. DNA or RNA coding for different human prion proteins including the mutated sequences associated with CJD, GSS and FFI were injected into muscle tissue. The mice were primarily inoculated with DNA-plasmids encoding PRNP and boosted either with DNA, RNA or recombinant Semliki Forest virus (SFV) particles expressing PRNP. After hybridoma preparation, different mAbs against prion proteins were obtained and their binding behaviour was analysed by peptide-ELISA, Western blot, immunofluorescence and immunoprecipitation. Our mAbs are directed against four different linear epitopes and may also recognize discontinuous regions of the native prion protein. It could, therefore, be demonstrated that immunization of non tolerant mice with DNA and live attenuated SF virus is a valuable means to induce a broad immune response leading eventually to the generation of a panel of mAbs for basic science as well as for diagnostics.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Prions/immunology , Amino Acid Sequence , Animals , Biotechnology , Cell Line , DNA/genetics , DNA/immunology , Epitopes/genetics , Genetic Vectors , Humans , Immunization , Mice , Molecular Sequence Data , Prion Diseases/diagnosis , Prion Diseases/immunology , Prions/genetics , RNA/genetics , RNA/immunology , Semliki forest virus/genetics , Transfection
17.
Br J Dermatol ; 141(1): 44-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10417514

ABSTRACT

The aetiology of mycosis fungoides (MF) and Sézary syndrome (SS) is unknown. A pathogenic role for the human T-cell lymphotropic virus type 1 (HTLV-1) has been suggested but remains controversial. We used an animal model to test the possibility that peripheral blood mononuclear cells (PBMC) obtained from MF patients harbour the HTLV-1 virus which may be infective. The polymerase chain reaction (PCR) was used to detect HTLV-1 proviral DNA sequences in PBMC of 27 MF patients and one SS patient of non-Iranian origin. Positive results were found in six of the patients. Twelve of the 28 patients tested by Western blot showed HTLV-1 antibodies. Twenty-eight immunosuppressed inbred Fisher F344 rats were inoculated intravenously with cultures of PBMC obtained from the 28 patients. Eight of these 28 rats showed antibodies to HTLV-1 while the proviral genome was demonstrated in the blood of only two of the rats. PBMC from two MF patients, in spite of showing negative results for the proviral genome by PCR, still induced HTLV-1 antibody formation in the F344 rat model. None of 10 control rats inoculated with normal donor PBMC showed antibodies to HTLV-1, nor the proviral genome. The present study suggests that HTLV-1 plays a cofactor role in MF/SS patients.


Subject(s)
Deltaretrovirus Infections/complications , Deltaretrovirus/pathogenicity , Mycosis Fungoides/virology , Sezary Syndrome/virology , Skin Neoplasms/virology , Adoptive Transfer , Adult , Aged , Animals , Blotting, Western , DNA, Viral/analysis , Deltaretrovirus/genetics , Deltaretrovirus/immunology , Deltaretrovirus Antibodies/blood , Deltaretrovirus Infections/immunology , Deltaretrovirus Infections/transmission , Female , Humans , Injections, Intravenous , Male , Middle Aged , Mycosis Fungoides/immunology , Polymerase Chain Reaction , Rats , Rats, Inbred F344 , Sezary Syndrome/immunology , Skin Neoplasms/immunology
18.
Naturwissenschaften ; 86(5): 212-20, 1999 May.
Article in English | MEDLINE | ID: mdl-10360268

ABSTRACT

Detection of PrP and its pathological isoform(s) is the key to understanding the etiology and pathogenesis of transmissible spongiform encephalopathy. There is ample evidence that PrP isoforms constitute a major component of an unknown and perhaps unconventional infectious agent. An etiological relationship between human and zoonotic transmissible spongiform encephalopathies may be revealed with monoclonal antibodies. Knowledge of the conformational transition rendering a non-pathogenic, almost ubiquitous cellular protein into a pathogenic one is crucial to defining pathomechanisms. The stepwise or even continuous formation of pathogenic molecules can be monitored. Any improvement in the early diagnosis could help to conceive new therapeutic measures which are not currently available. Determination of PrP isoforms in tissue, cells, or body fluids may be of prognostic value. Many experimental approaches in molecular medicine and molecular biology of the prion protein already rely on monoclonal antibodies. Recombinant antibodies such as the single-chain Fv may soon replace traditional hybridoma techniques. Binding affinity can easily be manipulated by a number of techniques, including in vitro mutagenesis--a step which could never be carried out using the traditional hybridoma technology. Monoclonal antibodies are and will remain an essential support for ongoing research on the prion protein in general and on the unconventional infectious prions.


Subject(s)
Antibodies, Monoclonal , Brain/pathology , Prion Diseases/pathology , Prions/analysis , Antibodies, Monoclonal/chemistry , Epitopes/analysis , Epitopes/chemistry , Humans , Prions/chemistry , Prions/immunology , Protein Isoforms/analysis , Protein Isoforms/chemistry , Protein Isoforms/immunology , Protein Structure, Secondary
20.
Article in English | MEDLINE | ID: mdl-10096586

ABSTRACT

We tested the possibility that lymphocytes and serum obtained directly from a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) induce infection in rats. Inbred Fischer F344 immunosuppressed rats were inoculated intravenously with 10x10(6) peripheral blood mononuclear cells (PBMC; 3 rats) and serum (3 rats) obtained from a HAM/TSP patient, who was seropositive and polymerase chain reaction (PCR)-positive for the HTLV-I proviral genome. Antibodies to HTLV-I appeared in the rat sera 2 months later; rat peripheral blood lymphocytes, spleen, salivary gland, and spinal cord were found to contain the proviral genome. Control rats inoculated with normal donor PBMC and serum tested negative for the HTLV-I antibodies and for the HTLV-I proviral genome by PCR. The positive control F344 rats inoculated with 5x10(6) cells of a SLB-1 HTLV-I cell line were found to be infected after 2 months. This study demonstrates for the first time that HTLV-I can be transmitted not only by human cellular components but also by human cell-free sera in a rat model.


Subject(s)
Amyotrophic Lateral Sclerosis/virology , HTLV-I Infections/transmission , Paraparesis, Tropical Spastic/virology , Adult , Amyotrophic Lateral Sclerosis/blood , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Disease Models, Animal , Female , HTLV-I Infections/virology , Human T-lymphotropic virus 1/genetics , Human T-lymphotropic virus 1/immunology , Humans , Leukocytes, Mononuclear/virology , Paraparesis, Tropical Spastic/blood , Paraparesis, Tropical Spastic/physiopathology , Rats , Rats, Inbred F344
SELECTION OF CITATIONS
SEARCH DETAIL
...